New thyroid formula is ‘good quality’

Medicine safety agency ANSM has confirmed the ‘good quality’ of a new, controversial formula of the thyroid drug Levothyrox after doing its own analysis of it.

Connexion journalist Connexion journalist

Published Tuesday 31 July 2018 - 16:38 Modified Tuesday 31 July 2018 - 16:38

Levothyrox - manufactured by laboratory Merck - is the most widely-used treatment option for patients suffering from thyroid conditions, which can cause weight gain, depression, circulation problems, coldness and extreme fatigue.

The new formula has been contested by patient association l’Association Française des Malades de la Thyroïde which has reported many complaints and says it is ineffective and causes side effects including headaches and dizziness.

French prefecture threatens to suspend licences for using phone when driving

Motorists could be without licence for up to six months. A trial period next month will decide on course of action

French workers who fall sick on holiday can now get holiday days back

Landmark ruling seeks to apply EU law after France was warned of non-compliance

‘I am a gatekeeper of this village’s memory’ – French honorary mayor

Mayor Jean-Pierre Laparra talks to us about representing a town that was wiped out in the battle of Verdun

Letters: Don't expect French language testing centres to have English keyboards

Connexion readers on having to use the Azerty rather than Qwerty keyboards

New French PM targets 30-minute health access for all

Network of 5,000 'France Santé' centres planned by 2027

Why French air controllers called off September 18 strike and instead plan October action

Three-day stoppage will impact air travel early next month

Listen: Stag bellowing season to begin in French forests

Every year, nature-lovers gather to listen out for the sound and even compete to imitate it best. A 500-hour livestream is available of the bellowing season on TV this year